Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis.

cardiac AL amyloidosis echocardiography histomorphology left atrial strain (LA strain) mortality pathology stem cell transplant (SCT)

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2022
Historique:
received: 18 10 2022
accepted: 30 12 2022
entrez: 10 2 2023
pubmed: 11 2 2023
medline: 11 2 2023
Statut: epublish

Résumé

This study examined the role of echocardiographic and cardiac histomorphology parameters in predicting mortality in patients with cardiac AL amyloidosis. Patients with endomyocardial biopsy-proven cardiac AL amyloidosis treated at MD Anderson Cancer Center between 6/2011 and 6/2020 were identified. Stored echocardiographic images and endomyocardial biopsy samples were processed for myocardial strain analysis and a detailed histomorphology characterization. Of 43 patients; 44% were women and 63% white. Median age was 65 years; 51% underwent stem cell transplantation (SCT). Thirty patients (70%) died during follow up (median follow up: 4.1 years). Lower LA strain (<13.5%) and absence of SCT as a time-varying covariate were significantly associated with increased risk of death in the multivariate cox regression analysis. Higher LV mass and lower RV tricuspid annular plane systolic excursion were associated with increased odds of having ≥5% interstitial amyloid deposition on biopsy in the multivariate logistic regression analysis. Lower LA strain independently predicted mortality in our cohort, and its performance in the routine assessment of AL amyloidosis may be beneficial. Furthermore, SCT for cardiac AL amyloidosis was associated with improved OS. These findings need to be confirmed by larger studies in the era of contemporary systemic therapies.

Identifiants

pubmed: 36762300
doi: 10.3389/fcvm.2022.1073804
pmc: PMC9902366
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1073804

Informations de copyright

Copyright © 2023 Koutroumpakis, Niku, Black, Ali, Sadaf, Song, Palaskas, Iliescu, Durand, Yusuf, Lee, Buja, Deswal and Banchs.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

ESC Heart Fail. 2021 Dec;8(6):5594-5599
pubmed: 34528755
J Am Coll Cardiol. 2016 Sep 20;68(12):1323-41
pubmed: 27634125
Blood. 2019 Jan 17;133(3):215-223
pubmed: 30333122
Histopathology. 2016 Apr;68(5):648-56
pubmed: 26212778
BMC Cardiovasc Disord. 2021 Jan 21;21(1):43
pubmed: 33478398
Methodist Debakey Cardiovasc J. 2012 Jul-Sep;8(3):8-16
pubmed: 23227279
Blood. 2015 Jul 30;126(5):612-5
pubmed: 25987656
JACC CardioOncol. 2019 Sep 24;1(1):117-130
pubmed: 34396169
World J Transplant. 2016 Jun 24;6(2):380-8
pubmed: 27358783
Eur Heart J Cardiovasc Imaging. 2020 May 1;21(5):542-548
pubmed: 31292624
Blood. 1992 Apr 1;79(7):1817-22
pubmed: 1558973
Echocardiography. 2017 Mar;34(3):365-370
pubmed: 28185312
JACC CardioOncol. 2021 Oct 19;3(4):467-487
pubmed: 34729520
J Am Soc Echocardiogr. 2022 Feb;35(2):154-164.e3
pubmed: 34416309
J Clin Oncol. 2004 Sep 15;22(18):3751-7
pubmed: 15365071
J Am Coll Cardiol. 2016 Jul 5;68(1):13-24
pubmed: 27364045
JACC Cardiovasc Imaging. 2010 Apr;3(4):333-42
pubmed: 20394893
J Am Heart Assoc. 2021 Oct 19;10(20):e020358
pubmed: 34622675
J Clin Oncol. 2012 Mar 20;30(9):989-95
pubmed: 22331953

Auteurs

Efstratios Koutroumpakis (E)

Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Adam Niku (A)

Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Christopher K Black (CK)

Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Abdelrahman Ali (A)

Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Humaira Sadaf (H)

Department of Pathology and Laboratory Medicine, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX, United States.

Juhee Song (J)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Nicolas Palaskas (N)

Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Cezar Iliescu (C)

Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Jean-Bernard Durand (JB)

Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Syed Wamique Yusuf (SW)

Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Hans C Lee (HC)

Division of Cancer Medicine, Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

L Maximilian Buja (LM)

Department of Pathology and Laboratory Medicine, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX, United States.

Anita Deswal (A)

Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Jose Banchs (J)

Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, United States.

Classifications MeSH